Related Experiment Video
Updated: Mar 28, 2026
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Medications, "Natural" Products, and Pharmacovigilance during Breastfeeding: A Mixed-Methods Study on Women's
Sofia Colaceci1, Angela Giusti2, Alessia De Angelis3
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy sofiacolaceci@gmail.com.
Background:
In cases of pharmacotherapy, mothers are confronted with the dilemma of breastfeeding and giving up the medication or discontinuing breastfeeding in order to take the drug, thus avoiding any potential risk for the infants.
Objective:
This study aimed to describe women's opinions on the use of medications and "natural" products during breastfeeding, pharmacovigilance and phytosurveillance, and the management of breastfeeding.
Methods:
This was a mixed-methods study with a sequential exploratory design. In the first qualitative phase, we conducted focus groups and in-depth interviews with 25 mothers attending community services. Coding and content analysis were carried out using NVivo9. We identified 4 main categories, and on this basis, we built a questionnaire administered to 248 pregnant women and new mothers attending 2 third-level hospitals. We conducted a descriptive and bivariate analysis (P ≤ .05) using Epi-Info v.7.
Results:
Women show 3 main attitudes: (1) to discontinue breastfeeding in order to take the medication, (2) to "endure the pain," or (3) to use so-called natural products, perceived safer than drugs. Women expressing an "endure the pain" opinion and women who considered natural products to be safer than medications had a higher probability of knowing that babies should be exclusively breastfed for the first 6 months (respectively, odds ratio [OR] = 2.24; 95% confidence interval [CI], 1.26-3.97; OR = 4.77; 95% CI, 2.56-8.88).
Conclusion:
In the dilemma of the mothers needing drug treatment, health professionals play a crucial role. They should convey evidence-based information on the compatibility of drugs with breastfeeding and provide individualized treatments, tailored to the single mother-baby case.
More Related Videos
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:29Therapeutic Drug Monitoring: Affecting Factors
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:28Dosage Regimens: Designs and Approaches
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...